KITY Study Protocol: A Randomised Controlled Trial for Eczema Prevention by Ingestion of Kestose in High-Risk Neonates
Clin Exp Allergy
.
2024 Dec 18.
doi: 10.1111/cea.14612.
Online ahead of print.
Authors
Mayako Saito-Abe
1
,
Kenji Toyokuni
1
,
Hisako Ogasawara
1
,
Kyongsun Pak
2
,
Yusuke Inuzuka
1
,
Daisuke Harama
1
,
Nozomi Ando
3
,
Yutaka Koyano
3
,
Tohru Kobayashi
4
,
Yuka Hayashi
5
,
Hideaki Morita
1
5
,
Kenji Matsumoto
5
,
Tatsuki Fukuie
1
,
Yukihiro Ohya
1
,
Kiwako Yamamoto-Hanada
1
Affiliations
1
Allergy Center, National Center for Child Health and Development, Tokyo, Japan.
2
Division of Biostatistics, Clinical Research Center, National Center for Child Health and Development, Tokyo, Japan.
3
Natural Science Co. Ltd., Tokyo, Japan.
4
Clinical Research Center, National Center for Child Health and Development, Tokyo, Japan.
5
Department of Allergy and Clinical Immunology, National Research Institute for Child Health and Development, Tokyo, Japan.
PMID:
39692192
DOI:
10.1111/cea.14612
No abstract available
Keywords:
atopic dermatitis; eczema; kestose; paediatrics; prebiotics; prevention.
Grants and funding
Natural Science Co. Ltd.,